Transapical transcatheter aortic valve implantation in a heart transplant recipient with severely depressed left ventricular function

Interact Cardiovasc Thorac Surg. 2013 Jun;16(6):906-8. doi: 10.1093/icvts/ivt048. Epub 2013 Mar 3.

Abstract

Transcatheter aortic valve implantation (TAVI) is becoming a valuable alternative to surgical aortic valve replacement in non-operable and high-risk surgical patients. As the population of heart donors and recipients ages, the prevalence of degenerative valvular disease after transplantation will increase. The optimal treatment strategy of valvulopathies in these patients with extensive comorbidity is still unknown because of insufficient published experience. We present a heart transplant recipient with renal failure, systolic heart failure and severe aortic stenosis who was successfully treated with transapical TAVI.

Keywords: Heart failure; Transcatheter aortic valve implantation; Transplant.

Publication types

  • Case Reports

MeSH terms

  • Aortic Valve Stenosis / diagnosis
  • Aortic Valve Stenosis / etiology
  • Aortic Valve Stenosis / physiopathology
  • Aortic Valve Stenosis / surgery*
  • Cardiac Catheterization*
  • Echocardiography
  • Heart Failure, Systolic / diagnosis
  • Heart Failure, Systolic / etiology
  • Heart Failure, Systolic / physiopathology*
  • Heart Transplantation* / adverse effects
  • Heart Valve Prosthesis Implantation / methods*
  • Humans
  • Male
  • Middle Aged
  • Renal Insufficiency / etiology
  • Severity of Illness Index
  • Treatment Outcome
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Left / physiopathology*
  • Ventricular Function, Left*